These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

91 related items for PubMed ID: 2382234

  • 21. Nonmitogenic anti-CD3F(ab')2 fragments inhibit lethal murine graft-versus-host disease induced across the major histocompatibility barrier.
    Blazar BR, Taylor PA, Snover DC, Bluestone JA, Vallera DA.
    J Immunol; 1993 Jan 01; 150(1):265-77. PubMed ID: 8417127
    [Abstract] [Full Text] [Related]

  • 22. Monotherapy with LF 15-0195, an analogue of 15-deoxyspergualin, significantly prolongs renal allograft survival in monkeys.
    Yang H, Chen G, Kanai N, Shum J, Garcia B, Huang X, Min W, Luo Y, Dutartre P, Zhong R.
    Transplantation; 2003 Apr 27; 75(8):1166-71. PubMed ID: 12717197
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Mechanism of action of anti-IL-2R monoclonal antibodies. ART-18 prolongs cardiac allograft survival in rats by elimination of IL-2R+ mononuclear cells.
    Tanaka K, Hancock WW, Osawa H, Stunkel KG, Alberghini TV, Diamantstein T, Tilney NL, Kupiec-Weglinski JW.
    J Immunol; 1989 Nov 01; 143(9):2873-9. PubMed ID: 2530281
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Nonhuman primate responses to murine and humanized OKT4A.
    Delmonico FL, Cosimi AB, Kawai T, Cavender D, Lee WH, Jolliffe LK, Knowles RW.
    Transplantation; 1993 Apr 01; 55(4):722-8. PubMed ID: 8475542
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. CD4 monoclonal antibody VIT4 in human alloimmune response in vitro and in vivo.
    Nachbaur D, Niederwieser D, Aichinger G, Aulitzky W, Tilg H, Eibl B, König P, Gattringer C, Majdic O, Stockinger H, Margreiter R, Oberhuber G, Födinger AM, Schwaighofer H, Huber C.
    Immunobiology; 1996 Jan 01; 195(1):33-46. PubMed ID: 8852599
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Muromonab CD-3: a review of its pharmacology, pharmacokinetics, and clinical use in transplantation.
    Hooks MA, Wade CS, Millikan WJ.
    Pharmacotherapy; 1991 Jan 01; 11(1):26-37. PubMed ID: 1902291
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Prolongation of heterotopic human corneal graft survival in mice treated with an anti-CD4 monoclonal antibody.
    Duguid IG, Koulmanda M, Mandel TE.
    Transplant Proc; 1990 Oct 01; 22(5):2107-8. PubMed ID: 2219310
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. OKT4A (a murine IgG2a anti-CD4 monoclonal antibody) in human organ transplantation: pharmacokinetics and peripheral pharmacodynamics.
    Henell KR, Cheever JM, Kimball JA, Lye WC, Munar MY, Misiti J, Vitow C, Norman DJ.
    Transplant Proc; 1993 Feb 01; 25(1 Pt 1):800-1. PubMed ID: 8438489
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 5.